-
US suspends Iran oil sanctions, says nuclear inspectors to return
-
Two children die in France as heatwave blasts Europe
-
Stokes and Atkinson cleared by Cricket Regulator after nightclub incident
-
Ex-Wimbledon champion Vondrousova banned four years for refusing drugs test
-
Veteran Le Roy named new coach of Congo
-
Milan-Cortina chief Malago elected new head of Italian FA
-
Germany's Schlotterbeck out of World Cup with ankle injury
-
Any unfreezing of Iranian funds will not finance terrorism: Vance
-
Vance hails 'good foundation' for Iran deal after direct talks
-
Alan Greenspan: longtime Fed chief with a divided legacy
-
Leinster boss Cullen to step down at end of next season
-
'Has-been' Belgium stars scorched after Iran World Cup draw
-
Oil falls on US-Iran progress; pound holds up as Starmer resigns
-
Starmer resigns as UK PM, Burnham favourite to take over
-
France, Germany reach deal on arms maker KNDS, paving way for IPO
-
Latest developments on Europe's heatwave
-
France set for hottest day yet of heatwave
-
Keir Starmer: downfall of UK's unpopular PM
-
Gaza's surfers seek solace in the sea
-
MEXC Lists Arcium (ARX) with 70,000 USDT in Airdrop+ Rewards
-
EasyJet rejects £5 bn takeover offer from US equity firm
-
Europe scorched by latest heatwave
-
Mediators hail 'progress' in US-Iran talks after lengthy opening session
-
UK's Starmer resigns as prime minister
-
Coffee break: Starbucks Korea stores pause for training after 'Tank Day' fiasco
-
Rightist leaders congratulate Colombian president-elect
-
Rare Philippine school shooting kills three teens, wounds seven
-
Kenya labour minister accused over Russian forced recruitment
-
Crude prices drop after 'positive' US-Iran talks
-
Some France schools closed for day of searing heat
-
Tuchel's England face defensive questions despite flying start at World Cup
-
Frankfurt to All Blacks: New Zealand pick first German-born player
-
Not just a hideout: Sahel forests provide base for jihadists
-
Ageless Messi has World Cup scoring record in his sights
-
Africa faces child surgery crisis as key anaesthesia runs out
-
Trump-backed populist wins razor-tight Colombia vote, sparking protests
-
J-Bay: S.Africa's surf mecca missing out on the global tour
-
'Progress', say mediators, after Iran-US talks towards ending war
-
Key points from the first round of Iran-US talks
-
European countries close schools, cancel trains as heatwave set to intensify
-
Crude prices drop, most stocks rise on 'positive' US-Iran talks
-
'Progress', say mediators, after Iran-US talks on ending war
-
Slimy beans: Japanese natto disgusts and delights the world
-
Clark wins despite hecklers but hopes not to be 'heel of the PGA'
-
Cape Verde targeting World Cup knockout rounds after Uruguay draw: coach
-
Father's Day near-miss at US Open brings Burns to tears
-
New coach Rennie names Savea as All Blacks captain
-
Scheffler praises Clark's resolve in gutsy US Open triumph
-
Yamal kickstarts Spain World Cup bid as Cape Verde stun Uruguay
-
Cape Verde fight back for second World Cup draw against Uruguay
US panel recommends nonprescription use of contraception pill
A US panel of health experts voted Wednesday in favor of making birth control pills available without a prescription, a move backed by reproductive rights advocates especially in the wake of a Supreme Court ruling overturning the national right to abortion.
The independent panel voted unanimously that the benefits of allowing the medicine, Opill, to be sold over the counter, outweighed the risks and would reduce hurdles associated with visiting a doctor that impact lower income groups disproportionately.
"I believe that the efficacy and safety of this birth control form was established over half a century ago," said panelist Jolie Haun of the James A. Haley Veterans' Hospital.
"We now have been presented with ample data demonstrating the effective safe use and benefits for people who want to have access to reproductive autonomy."
The committee's votes are usually accepted by the Food and Drug Administration, which means the pill, which is made by HRA Pharma, might be available without prescription in the coming weeks.
While likely, approval is not assured. FDA scientists highlighted safety concerns, such as the potential impact on people with a history or current diagnosis of breast cancer, or whether they would understand the pill needs to be taken the same time every day to prevent pregnancy.
"There is also concern that some consumers may not consistently use the product correctly on a chronic basis and be at risk for pregnancy, but not recognize that they are pregnant because of the irregular bleeding that would be ascribed to the known side effect," the FDA wrote in a document.
The push for a non-prescription pill has taken on new urgency in light of a Supreme Court decision overturning the constitutional right to abortion, leading to numerous bans and severe restrictions in conservative states.
It has received support from health groups such as the American Medical Association and American College of Obstetricians and Gynecologists.
If the pill is approved, the US would join more than 100 other countries where the pill is available without a prescription, including the UK which requires a consultation with a pharmacist.
Opill is known as a "mini pill" because it contains progestin only.
Another company, Cadence, is in talks with the FDA about making its combination pill, which contains both estrogen and progestin, available over the counter.
K.Thomson--BTB